Founded in 1998500+ safe and successful trialsExemplary safety recordCutting-edge technologyPhase I specialist
Medimmune
MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca.
Website: https://www.astrazeneca.com/